DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 163 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $256,000 | -6.9% | 7,522 | 0.0% | 0.08% | -4.7% |
| Q2 2021 | $275,000 | -18.4% | 7,522 | 0.0% | 0.08% | -19.8% |
| Q1 2021 | $337,000 | -25.9% | 7,522 | -5.6% | 0.11% | -28.4% |
| Q4 2020 | $455,000 | +114.6% | 7,971 | +92.5% | 0.15% | +85.0% |
| Q3 2020 | $212,000 | -13.1% | 4,140 | +1.4% | 0.08% | -18.4% |
| Q2 2020 | $244,000 | – | 4,081 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $18,687,872 | 15.44% |
| Redmile Group, LLC | 5,582,105 | $86,243,522 | 3.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,218,638 | $80,627,957 | 1.80% |
| BRAIDWELL LP | 3,241,351 | $50,078,873 | 1.65% |
| Parkman Healthcare Partners LLC | 491,772 | $7,597,877 | 1.65% |
| Sunesis Advisors, LLC | 96,299 | $1,487,820 | 1.07% |
| ARMISTICE CAPITAL, LLC | 4,100,000 | $63,345,000 | 0.91% |
| Deep Track Capital, LP | 1,363,201 | $21,061,455 | 0.86% |
| AlphaCentric Advisors LLC | 72,500 | $1,120,125 | 0.77% |
| Ikarian Capital, LLC | 174,510 | $2,696,179 | 0.61% |